Hep C - Transgene Biotek to roll out new vaccines, invest in infrastructure upgradation
Transgene Biotek to roll out new vaccines, invest in infrastructure upgradation
PharmaBiz - Jan 06 6:50 PM
The Hyderabad-based Transgene Biotek is working on various human vaccines such as Meningococcal meningitis, conjugate vaccines and a Hep A + Hep B combination vaccine. These vaccines will mostly be supplied to the WHO, UNICEF and the third world countries.Save to My Web
Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R) Approved In Japan
Medical News Today - Dec 27 4:15 PM
Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.K., the company's country operations in Japan, has received marketing approval for a new, additional indication for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection in combination with REBETOL(R) (ribavirin) Capsules -- the treatment of chronic hepatitis C in adult patients other than those with genotype 1 virus Save to My Web
Schering-Plough Announces PEG-INTRON(R) and REBETOL(R) Approved in Japan for Expanded Use in Treating Chronic Hepatitis
[Press Release] PR Newswire via Yahoo! Finance - Dec 22 5:30 AM
Schering-Plough Corporation today announced that Schering-Plough K.K., the company's country operations in Japan, has received marketing approval for a new, additional indication for PEG-INTRON Powder for Injection in combination with REBETOL Capsules -- the treatment of chronic hepatitis C in adult patients other than those with genotype 1 virus and high viral load.Save to My Web
George A. Scangos, Ph.D., Named Chairman of the Board of Anadys Pharmaceuticals
[Press Release] PR Newswire via Yahoo! Finance - Dec 15 4:30 PM
Anadys Pharmaceuticals, Inc. announced today that George A. Scangos, Ph.D., a member of the Board of Directors, will assume the position of Chairman, effective December 31, 2005.Save to My Web
